JPH0692871A - Ｎｍｒ画像用造影剤及びペプチド構造からなるキレート化剤 - Google Patents

Ｎｍｒ画像用造影剤及びペプチド構造からなるキレート化剤

Info

Publication number: JPH0692871A
Authority: JP; Japan
Prior art keywords: contrast agent; complex; formula; paramagnetic metal; agent according
Prior art date: 1990-06-26
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Pending

Application number

JP3182034A

Other languages

English (en)

Japanese (ja)

Inventor

Kwok W Chiu

クウォク、ワイ、チウ

Wassif Hussain

ワシフ、ユサン

John R Thornback

ジョン、リチャード、ソーンバック

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Medgenix Group SA

Original Assignee

Medgenix Group SA

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-06-26

Filing date

1991-06-26

Publication date

1994-04-05

1991-06-26 Application filed by Medgenix Group SA filed Critical Medgenix Group SA

1994-04-05 Publication of JPH0692871A publication Critical patent/JPH0692871A/ja

Status Pending legal-status Critical Current

Links

239000002872 contrast media Substances 0.000 title claims abstract description 56
239000002738 chelating agent Substances 0.000 title claims description 24
108090000765 processed proteins & peptides Proteins 0.000 title claims description 4
230000005298 paramagnetic effect Effects 0.000 claims abstract description 33
229910052751 metal Inorganic materials 0.000 claims abstract description 22
239000002184 metal Substances 0.000 claims abstract description 22
150000001768 cations Chemical class 0.000 claims abstract description 17
229910052736 halogen Inorganic materials 0.000 claims abstract description 11
150000002367 halogens Chemical class 0.000 claims abstract description 11
125000003545 alkoxy group Chemical group 0.000 claims abstract description 8
125000000217 alkyl group Chemical group 0.000 claims abstract description 8
125000003342 alkenyl group Chemical group 0.000 claims abstract description 4
125000003118 aryl group Chemical group 0.000 claims abstract description 4
125000003710 aryl alkyl group Chemical group 0.000 claims abstract description 3
150000001875 compounds Chemical class 0.000 claims description 21
150000003839 salts Chemical class 0.000 claims description 15
238000004519 manufacturing process Methods 0.000 claims description 14
239000002253 acid Substances 0.000 claims description 11
150000002500 ions Chemical class 0.000 claims description 10
238000000034 method Methods 0.000 claims description 10
238000003384 imaging method Methods 0.000 claims description 9
150000001450 anions Chemical class 0.000 claims description 6
125000001424 substituent group Chemical group 0.000 claims description 5
239000008346 aqueous phase Substances 0.000 claims description 4
239000007864 aqueous solution Substances 0.000 claims description 4
150000004696 coordination complex Chemical class 0.000 claims description 3
125000000753 cycloalkyl group Chemical group 0.000 claims description 3
150000002825 nitriles Chemical class 0.000 claims description 3
125000000449 nitro group Chemical class [O-][N+](*)=O 0.000 claims description 3
150000007530 organic bases Chemical class 0.000 claims description 3
239000000725 suspension Substances 0.000 claims description 3
125000003277 amino group Chemical group 0.000 claims description 2
150000003863 ammonium salts Chemical class 0.000 claims description 2
229910052723 transition metal Inorganic materials 0.000 claims description 2
150000003624 transition metals Chemical class 0.000 claims description 2
125000004178 (C1-C4) alkyl group Chemical group 0.000 claims 1
229910052688 Gadolinium Inorganic materials 0.000 claims 1
125000000524 functional group Chemical group 0.000 claims 1
UIWYJDYFSGRHKR-UHFFFAOYSA-N gadolinium atom Chemical compound [Gd] UIWYJDYFSGRHKR-UHFFFAOYSA-N 0.000 claims 1
229910052747 lanthanoid Inorganic materials 0.000 claims 1
150000002602 lanthanoids Chemical class 0.000 claims 1
125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 1
238000006243 chemical reaction Methods 0.000 abstract description 3
231100000053 low toxicity Toxicity 0.000 abstract description 3
150000001457 metallic cations Chemical class 0.000 abstract description 3
230000037396 body weight Effects 0.000 abstract description 2
-1 Co<2+> Chemical class 0.000 abstract 1
150000002739 metals Chemical class 0.000 abstract 1
239000000126 substance Substances 0.000 description 20
RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 17
239000000243 solution Substances 0.000 description 14
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
210000004185 liver Anatomy 0.000 description 10
238000002360 preparation method Methods 0.000 description 10
210000001519 tissue Anatomy 0.000 description 10
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
210000000056 organ Anatomy 0.000 description 9
DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 8
238000002595 magnetic resonance imaging Methods 0.000 description 7
238000005259 measurement Methods 0.000 description 7
239000007787 solid Substances 0.000 description 7
YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
QPCDCPDFJACHGM-UHFFFAOYSA-N N,N-bis{2-[bis(carboxymethyl)amino]ethyl}glycine Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(=O)O)CCN(CC(O)=O)CC(O)=O QPCDCPDFJACHGM-UHFFFAOYSA-N 0.000 description 6
210000003734 kidney Anatomy 0.000 description 6
230000005291 magnetic effect Effects 0.000 description 6
239000000203 mixture Substances 0.000 description 6
230000003595 spectral effect Effects 0.000 description 6
125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 6
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 5
241000700159 Rattus Species 0.000 description 5
238000001914 filtration Methods 0.000 description 5
239000004471 Glycine Substances 0.000 description 4
CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 4
125000000896 monocarboxylic acid group Chemical group 0.000 description 4
238000003756 stirring Methods 0.000 description 4
XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
CJUMAFVKTCBCJK-UHFFFAOYSA-N N-benzyloxycarbonylglycine Chemical compound OC(=O)CNC(=O)OCC1=CC=CC=C1 CJUMAFVKTCBCJK-UHFFFAOYSA-N 0.000 description 3
230000000694 effects Effects 0.000 description 3
229910052739 hydrogen Inorganic materials 0.000 description 3
125000004435 hydrogen atom Chemical group [H]* 0.000 description 3
238000002347 injection Methods 0.000 description 3
239000007924 injection Substances 0.000 description 3
238000010253 intravenous injection Methods 0.000 description 3
239000007788 liquid Substances 0.000 description 3
239000011541 reaction mixture Substances 0.000 description 3
210000000952 spleen Anatomy 0.000 description 3
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
OKTJSMMVPCPJKN-OUBTZVSYSA-N Carbon-13 Chemical compound [13C] OKTJSMMVPCPJKN-OUBTZVSYSA-N 0.000 description 2
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 2
NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 2
125000004429 atom Chemical group 0.000 description 2
239000008280 blood Substances 0.000 description 2
210000004369 blood Anatomy 0.000 description 2
239000013522 chelant Substances 0.000 description 2
239000003795 chemical substances by application Substances 0.000 description 2
239000000084 colloidal system Substances 0.000 description 2
238000003745 diagnosis Methods 0.000 description 2
239000003480 eluent Substances 0.000 description 2
238000001704 evaporation Methods 0.000 description 2
230000008020 evaporation Effects 0.000 description 2
230000005284 excitation Effects 0.000 description 2
239000000706 filtrate Substances 0.000 description 2
239000001257 hydrogen Substances 0.000 description 2
XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
MGFYIUFZLHCRTH-UHFFFAOYSA-N nitrilotriacetic acid Chemical compound OC(=O)CN(CC(O)=O)CC(O)=O MGFYIUFZLHCRTH-UHFFFAOYSA-N 0.000 description 2
230000035515 penetration Effects 0.000 description 2
230000035699 permeability Effects 0.000 description 2
238000010898 silica gel chromatography Methods 0.000 description 2
229910000029 sodium carbonate Inorganic materials 0.000 description 2
PYOKUURKVVELLB-UHFFFAOYSA-N trimethyl orthoformate Chemical compound COC(OC)OC PYOKUURKVVELLB-UHFFFAOYSA-N 0.000 description 2
239000003039 volatile agent Substances 0.000 description 2
BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
102000008100 Human Serum Albumin Human genes 0.000 description 1
108091006905 Human Serum Albumin Proteins 0.000 description 1
VQTUBCCKSQIDNK-UHFFFAOYSA-N Isobutene Chemical group CC(C)=C VQTUBCCKSQIDNK-UHFFFAOYSA-N 0.000 description 1
KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium on carbon Substances [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 1
241001161108 Platyrhinoidis triseriata Species 0.000 description 1
239000008351 acetate buffer Substances 0.000 description 1
229910000147 aluminium phosphate Inorganic materials 0.000 description 1
150000001413 amino acids Chemical class 0.000 description 1
239000012491 analyte Substances 0.000 description 1
235000013405 beer Nutrition 0.000 description 1
HSDAJNMJOMSNEV-UHFFFAOYSA-N benzyl chloroformate Chemical compound ClC(=O)OCC1=CC=CC=C1 HSDAJNMJOMSNEV-UHFFFAOYSA-N 0.000 description 1
230000015572 biosynthetic process Effects 0.000 description 1
230000005587 bubbling Effects 0.000 description 1
239000000872 buffer Substances 0.000 description 1
239000002775 capsule Substances 0.000 description 1
HJMZMZRCABDKKV-UHFFFAOYSA-N carbonocyanidic acid Chemical compound OC(=O)C#N HJMZMZRCABDKKV-UHFFFAOYSA-N 0.000 description 1
239000003054 catalyst Substances 0.000 description 1
238000001816 cooling Methods 0.000 description 1
230000007423 decrease Effects 0.000 description 1
SPWVRYZQLGQKGK-UHFFFAOYSA-N dichloromethane;hexane Chemical compound ClCCl.CCCCCC SPWVRYZQLGQKGK-UHFFFAOYSA-N 0.000 description 1
YWEUIGNSBFLMFL-UHFFFAOYSA-N diphosphonate Chemical compound O=P(=O)OP(=O)=O YWEUIGNSBFLMFL-UHFFFAOYSA-N 0.000 description 1
230000005672 electromagnetic field Effects 0.000 description 1
150000002148 esters Chemical class 0.000 description 1
238000002474 experimental method Methods 0.000 description 1
238000000605 extraction Methods 0.000 description 1
IZOOGPBRAOKZFK-UHFFFAOYSA-K gadopentetate Chemical compound [Gd+3].OC(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O IZOOGPBRAOKZFK-UHFFFAOYSA-K 0.000 description 1
LGMLJQFQKXPRGA-VPVMAENOSA-K gadopentetate dimeglumine Chemical compound [Gd+3].CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O LGMLJQFQKXPRGA-VPVMAENOSA-K 0.000 description 1
238000000338 in vitro Methods 0.000 description 1
150000007529 inorganic bases Chemical class 0.000 description 1
230000002452 interceptive effect Effects 0.000 description 1
UQSXHKLRYXJYBZ-UHFFFAOYSA-N iron oxide Inorganic materials [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 1
150000002603 lanthanum Chemical class 0.000 description 1
239000000463 material Substances 0.000 description 1
229910021645 metal ion Inorganic materials 0.000 description 1
210000000865 mononuclear phagocyte system Anatomy 0.000 description 1
230000000877 morphologic effect Effects 0.000 description 1
230000007935 neutral effect Effects 0.000 description 1
229910052757 nitrogen Inorganic materials 0.000 description 1
229910052760 oxygen Inorganic materials 0.000 description 1
230000000149 penetrating effect Effects 0.000 description 1
DLYUQMMRRRQYAE-UHFFFAOYSA-N phosphorus pentoxide Inorganic materials O1P(O2)(=O)OP3(=O)OP1(=O)OP2(=O)O3 DLYUQMMRRRQYAE-UHFFFAOYSA-N 0.000 description 1
230000035479 physiological effects, processes and functions Effects 0.000 description 1
239000000047 product Substances 0.000 description 1
238000000746 purification Methods 0.000 description 1
230000002285 radioactive effect Effects 0.000 description 1
238000001953 recrystallisation Methods 0.000 description 1
230000035945 sensitivity Effects 0.000 description 1
239000002904 solvent Substances 0.000 description 1
239000012258 stirred mixture Substances 0.000 description 1
QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
238000003786 synthesis reaction Methods 0.000 description 1
239000003826 tablet Substances 0.000 description 1
150000005691 triesters Chemical class 0.000 description 1
210000001635 urinary tract Anatomy 0.000 description 1
239000008215 water for injection Substances 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/022—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/24—Nuclear magnetic resonance, electron spin resonance or other spin effects or mass spectrometry

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Genetics & Genomics (AREA)
Biochemistry (AREA)
Biophysics (AREA)
General Health & Medical Sciences (AREA)
Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Life Sciences & Earth Sciences (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)

JP3182034A 1990-06-26 1991-06-26 Ｎｍｒ画像用造影剤及びペプチド構造からなるキレート化剤 Pending JPH0692871A (ja)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR9008009A FR2663544B1 (fr)	1990-06-26	1990-06-26	Agent de contraste pour l'imagerie par rmn et agents chelateurs comportant des structures peptidiques.
FR9008009		1990-06-26

Publications (1)

Publication Number	Publication Date
JPH0692871A true JPH0692871A (ja)	1994-04-05

Family

ID=9398009

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
JP3182034A Pending JPH0692871A (ja)	1990-06-26	1991-06-26	Ｎｍｒ画像用造影剤及びペプチド構造からなるキレート化剤

Country Status (5)

Country	Link
US (1)	US5344639A (de)
EP (1)	EP0465295A1 (de)
JP (1)	JPH0692871A (de)
CA (1)	CA2045451A1 (de)
FR (1)	FR2663544B1 (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7325247B2 (en) *	1998-09-18	2008-01-29	Fujitsu Limited	Information management method using a recording medium with a secure area and a user-use area

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5405601A (en) *	1993-07-02	1995-04-11	Mallinckrodt Medical Inc.	Functionalized tripodal ligands for imaging applications
DE19507822B4 (de) *	1995-02-21	2006-07-20	Schering Ag	Substituierte DTPA-Monoamide der zentralen Carbonsäure und deren Metallkomplexe, diese Komplexe enthaltende pharmazeutische Mittel, deren Verwendung in der Diagnostik und Therapie sowie Verfahren zur Herstellung der Komplexe und Mittel
CA2442382A1 (en)	2001-04-03	2002-10-17	Theseus Imaging Corporation	Methods for using annexin for detecting cell death in vivo and treating associated conditions
US20050013778A1 (en) *	2001-04-03	2005-01-20	Theseus Imaging Corporation	Methods and compositions for predicting the response to a therapeutic regimen in a subject having a disease associated with cell death
US9011816B2 (en)	2011-03-25	2015-04-21	Case Western Reserve University	Fibronectin targeting contrast agent

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2683740A (en) *	1952-10-24	1954-07-13	Monsanto Chemicals	2, 2', 2'-nitrilotris
US3424790A (en) *	1966-05-11	1969-01-28	Dow Chemical Co	Process for preparing carboxymethylated polyethylenimine and products produced by the same
US4647447A (en) *	1981-07-24	1987-03-03	Schering Aktiengesellschaft	Diagnostic media
DE3347534A1 (de) *	1983-12-30	1985-07-11	Hoechst Ag, 6230 Frankfurt	Neue amphotere verbindungen, diese verbindungen enthaltende gemische zur desinfektionsreinigung sowie verfahren zur herstellung dieser verbindungen und gemische
US4639365A (en) *	1984-10-18	1987-01-27	The Board Of Regents, The University Of Texas System	Gadolinium chelates as NMR contrast agents
HU208947B (en) *	1987-07-16	1994-02-28	Nycomed As	Diagnostical compositions and process for producing aminopolycarboxylic acids, their derivatives and metal-kelates
GB8801646D0 (en) *	1988-01-26	1988-02-24	Nycomed As	Chemical compounds
US5137711A (en) *	1988-07-19	1992-08-11	Mallickrodt Medical, Inc.	Paramagnetic dtpa and edta alkoxyalkylamide complexes as mri agents
WO1990003804A1 (en) *	1988-09-27	1990-04-19	Salutar, Inc.	Chelate compositions

1990
- 1990-06-26 FR FR9008009A patent/FR2663544B1/fr not_active Expired - Fee Related
1991
- 1991-06-24 EP EP91401697A patent/EP0465295A1/de not_active Withdrawn
- 1991-06-25 CA CA002045451A patent/CA2045451A1/fr not_active Abandoned
- 1991-06-26 JP JP3182034A patent/JPH0692871A/ja active Pending
- 1991-06-26 US US07/719,715 patent/US5344639A/en not_active Expired - Fee Related

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7325247B2 (en) *	1998-09-18	2008-01-29	Fujitsu Limited	Information management method using a recording medium with a secure area and a user-use area

Also Published As

Publication number	Publication date
CA2045451A1 (fr)	1991-12-27
EP0465295A1 (de)	1992-01-08
FR2663544B1 (fr)	1994-05-06
US5344639A (en)	1994-09-06
FR2663544A1 (fr)	1991-12-27

Publication	Publication Date	Title
DE69032761T2 (de)	1999-04-22	Hydroxy-aryl metallchelate für bildformung zur nmr diagnose
US5077037A (en)	1991-12-31	Novel compositions for magnetic resonance imaging
EP0603403B1 (de)	1997-10-15	Neues chelatisierungsmittel, komplexverbindungen, die aus diesem mittel und metallatomen aufgebaut sind, und diagnostische mittel, die diese verbindungen enthalten
US5141740A (en)	1992-08-25	Complexes and compositions for magnetic resonance imaging and usage methods
US5527522A (en)	1996-06-18	Hydroxy-aryl metal chelates for diagnostic NMR imaging
US5318771A (en)	1994-06-07	Hydroxy-aryl metal chelates for diagnostic NMR imaging
US5565184A (en)	1996-10-15	Functionalized tripodal ligands for x-ray & radioactive imaging applications
JPH0920785A (ja)	1997-01-21	非イオン性常磁性イオン錯体およびこれを形成するための錯化剤
US5242681A (en)	1993-09-07	Lipophilic contrast agents for diagnostic image analysis
US5162109A (en)	1992-11-10	Magnetic resonance imaging agents
KR20190091441A (ko)	2019-08-06	다이머 조영제
US5138040A (en)	1992-08-11	Composition for magnetic resonance imaging
JPH0692871A (ja)	1994-04-05	Ｎｍｒ画像用造影剤及びペプチド構造からなるキレート化剤
US5314680A (en)	1994-05-24	Polyazamacrocycles for magnetic resonance imaging
US5208375A (en)	1993-05-04	Compositions for magnetic resonance imaging
US5858329A (en)	1999-01-12	MRI diagnostic procedures using tripodal pyridinyl metal complexes
KR100251427B1 (ko)	2000-05-01	신규의 킬레이트제, 상기 킬레이트제와 금속 원자의 착 화합물, 및 상기 화합물을 포함하는 진단제
US5869025A (en)	1999-02-09	Tripodal aromatic heterocycle carboxamide MRI contrast agents
JP3404787B2 (ja)	2003-05-12	新規ジエチレントリアミンペンタ酢酸誘導体、該誘導体と金属原子との錯化合物、及び該錯化合物を含む診断剤
US5820851A (en)	1998-10-13	Tripodal pyridine ligands as MRI contrast agents
US5824288A (en)	1998-10-20	Thio-substituted pyridines as MRI ligand precursors
US5869026A (en)	1999-02-09	Tripodal carboxamide ligands for MRI contrast agents
WO1995032004A1 (en)	1995-11-30	Functionalized bicyclo[2.2.1] heptane and [2.2.2] octane system as preorganized ligands for imaging applications
WO1994008630A1 (en)	1994-04-28	Novel compositions for magnetic resonance imaging
HK1012707B (en)	2000-05-12	Hydroxy-aryl metal chelates for diagnostic nmr imaging

JPH0692871A - Ｎｍｒ画像用造影剤及びペプチド構造からなるキレート化剤 - Google Patents

Info

Links

Classifications

Landscapes

Applications Claiming Priority (2)

Publications (1)

Family

ID=9398009

Family Applications (1)

Country Status (5)

Cited By (1)

Families Citing this family (5)

Family Cites Families (9)

Cited By (1)

Also Published As

Similar Documents